CNTA Centessa Pharmaceuticals plc
CNTA Centessa Pharmaceuticals plc
Healthcare · Biotechnology
Market read
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
CNTA Price Structure
Loading chart…
Loading timeframes…
COVERAGE GAP — this name's print date has passed and tonight's bounded news pass did not include it. No coverage was acquired; nothing is asserted about the result. Refill on the next daily or when the name earns a targeted pull.
full note →News (last pull)
Headlines about CNTA from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 36 days ago · Jul 13
- Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
- Centessa agrees to $38 cash plus CVR in Lilly acquisition | CNTA SEC Filing - Form DEFM14A
- Eli Lilly to Buy Centessa Pharmaceuticals for Up to $7.8bn in Neuro Push
- Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%
- Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
CNTA research tape
10 dated scans, research, and events, newest first — the full record.
Types